Latest Global Injectable Drug Delivery Devices Market SizeShare Worth USD 40,956.3 Million by 2033 at a 10.21 percent CAGR Custom Market Insights
| TMCAX Fund | USD 12.78 0.21 1.67% |
Slightly above 53% of Rbc Smid's investors are presently thinking to get in. The analysis of overall sentiment of trading Rbc Smid Cap mutual fund suggests that some investors are interested at this time. Rbc Smid's investing sentiment can be driven by a variety of factors including economic data, Rbc Smid's earnings reports, geopolitical events, and overall market trends.
Rbc |
220 Pages Latest Report According to a market research study published by Custom Market Insights, the demand analysis of Global Injectable Drug Delivery Devices Market size share revenue was valued at approximately USD 15,435.15 Million in 2023 and is expected to reach USD 17,032.08 Million in 2024 and is expected to reach around USD 40,956.3 Million by 2033, at a CAGR of 10.21 percent between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are
Read at finance.yahoo.com
 |
Rbc Smid Fundamental Analysis
We analyze Rbc Smid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rbc Smid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rbc Smid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Rbc Smid is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Rbc Smid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rbc Smid mutual fund to make a market-neutral strategy. Peer analysis of Rbc Smid could also be used in its relative valuation, which is a method of valuing Rbc Smid by comparing valuation metrics with similar companies.
Peers
Rbc Smid Related Equities
| ETCHX | Eventide Healthcare | 1.38 | ||||
| LHCCX | Lord Abbett | 1.30 | ||||
| THQ | Tekla Healthcare | 1.13 | ||||
| BHSRX | Blackrock Health | 1.06 | ||||
| DLHIX | Delaware Healthcare | 1.00 | ||||
| SCHLX | Deutsche Health | 0.15 | ||||
| SBHIX | Health Biotchnology | 0.09 | ||||
| BGHDX | Baillie Gifford | 0.00 |
Other Information on Investing in Rbc Mutual Fund
Rbc Smid financial ratios help investors to determine whether Rbc Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rbc with respect to the benefits of owning Rbc Smid security.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |